ArticleInternational journal of surgery case reports2026
Endometrioid endocervical adenocarcinoma in a postmenopausal woman: a case report and review of the literature.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Importance: Endometrioid adenocarcinoma of the uterine cervix is rare and difficult to distinguish from endometrial adenocarcinoma. It has been referred to as a diagnostic challenge, particularly due to rare endometrioid subtypes that can mimic endometrial carcinoma and are associated with a poorer prognosis. This report presents a case of rapidly progressing endometrioid adenocarcinoma to emphasize this unusual clinical course. Case Presentation: The 62-year-old patient (G2P2) with an unremarkable medical history presented with asymptomatic endometrial fluid detected on routine ultrasound. Subsequent workup, including fractional curettage and MRI, revealed cervical cancer, which was staged as FIGO IB1. The patient underwent radical hysterectomy with bilateral salpingo-oophorectomy and pelvic lymph node dissection, with final pathology revealing moderately differentiated endocervical adenocarcinoma (ECA) invading the endocervical canal and uterine isthmus, and negative lymph nodes. The patient had an uneventful postoperative recovery and remains disease-free at 6 months of follow-up. Clinical Discussion: This case highlights the diagnostic difficulty of endometrioid ECA, a rare non-HPV-associated subtype often misidentified as endometrial carcinoma. Rapid progression despite negative cytology underscores Pap smear limitations for glandular lesions. Early radical surgery with adjuvant therapy and multidisciplinary evaluation remain essential for optimizing patient outcomes. Conclusion: The diagnosis of endometrioid ECA is challenging due to its rarity, and determining the tumor's origin remains particularly difficult. Furthermore, the phenomenon of "rapid-onset" cervical carcinoma, often an adenocarcinoma, warrants attention because Pap smears have lower sensitivity for detecting glandular lesions than squamous lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.